A study published in the journal Nature Cancer, carried out within the Cancer Program at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, ...
Mar 17, 2022
0
143
Metastases in cancer are often caused by a few abnormal cells. These behave more aggressively than the other cancer cells in a tumor. Miao-Ping Chien and Daan Brinks, from two different universities, are working together ...
Mar 17, 2022
0
75
New research has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children. Scientists from the Wellcome ...
Mar 14, 2022
0
92
Hematopoietic stem cells (HSCs) have the capacity to both self-renew and differentiate into all mature blood cell types, making them promising treatments for a variety of diseases. However, the mechanisms involved in engraftment—when ...
Mar 1, 2022
0
28
Embryonic stem cells and other pluripotent cells divide rapidly and have the capacity to become nearly any cell type in the body. Scientists have long sought to understand the signals that prompt stem cells to switch off ...
Feb 21, 2022
0
425
A Te Herenga Waka–Victoria University of Wellington Ph.D. graduate who was based at the Gillies McIndoe Research Institute (GMRI) has found a potential new source of help for colon cancer patients—medications used to ...
Feb 18, 2022
0
29
Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in early 2021, the trials ground to a halt after reports of blood malignancies in two people in a trial sponsored ...
Feb 15, 2022
0
12
Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average ...
Feb 11, 2022
0
1096
Naked mole-rats (NMRs)—the longest living rodents—show remarkable resistance to aging and cancer. NMRs have long fascinated those involved in aging research and cancer research. Now, for the first time, researchers from ...
Feb 8, 2022
0
55
Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according ...
Feb 2, 2022
0
97
